Inventor · disambiguated record
Tatsuro Ishibashi
Also filed as: ISHIBASHI TATSURO
2 granted patents·11 pending applications·5 citations·filing 2005–2024
52Inventor score
Files withUNIV KYUSHU NAT UNIV CORP5UNIV OSAKA3AQUMEN BIOPHARMACEUTICALS K K2JAPAN VILENE CO LTD1KYUSHU UNIV NATL UNIV CORPORATION1
Top patents by PatentIndex Score
13 records- 0173US2024216390A1Therapeutic agent for ocular fundus diseaseKYUSHU UNIV NATL UNIV CORPORATION·Filed 2024·Application pending·0 cites
- 0266US10426783B2Therapeutic agent for ocular fundus diseaseUNIV KYUSHU NAT UNIV CORP·Filed 2016·Granted Oct 1, 2019·1 cites·7 claims
- 0365US7731941B2Staining composition for staining an ophthalmic membraneNAT UNIVERSITY CORP KYUSHU UNI·Filed 2005·Granted Jun 8, 2010·4 cites·6 claims
- 0464US2021163608A1Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredientUNIV OSAKA·Filed 2020·Application pending·0 cites
- 0559US2010129355A1Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredientUNIV OSAKA·Filed 2008·Application pending·0 cites
- 0655US2019365776A1Therapeutic agent for ocular fundus diseaseUNIV KYUSHU NAT UNIV CORP·Filed 2019·Application pending·0 cites
- 0753US2014378441A1Therapeutic agent for ocular fundus diseaseUNIV KYUSHU NAT UNIV CORP·Filed 2014·Application pending·0 cites
- 0851US2016339018A1Therapeutic agent for ocular fundus diseaseUNIV KYUSHU NAT UNIV CORP·Filed 2014·Application pending·0 cites
- 0950US2016326255A1Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredientUNIV OSAKA·Filed 2016·Application pending·0 cites
- 1047US2020108339A1Charged filter medium and method of producing charged filter mediumJAPAN VILENE CO LTD·Filed 2018·Application pending·0 cites
- 1141US2015105442A1Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin Gene, method for Inhibiting Expression of Periostin Gene, and Use of Said Nucleic Acid MoleculeUNIV KYUSHU NAT UNIV CORP·Filed 2013·Application pending·0 cites
- 1228US2009042778A1Methods for Suppressing Neovascularization Using Ephrinb2AQUMEN BIOPHARMACEUTICALS K K·Filed 2005·Application pending·0 cites
- 1328US2009270315A1Method of inhibiting angiogenesis by using ephrin b2AQUMEN BIOPHARMACEUTICALS K K·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tatsuro Ishibashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →